Prognostic impact of different TNM-based stage groupings for oral squamous cell carcinoma

Head and Neck

Volumn 33, Issue 10, 2011, Pages 1467-1475

  Kreppel, Matthias ^a,b   Drebber, Uta ^a,b   Rothamel, Daniel ^a,b   Eich, Hans Theodor ^a,b   Kübler, Alexander ^c   Scheer, Martin ^a,b   Zöller, Joachim E ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b University of Cologne   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

multivariate analysis; oral cancer; prognosis; stage grouping; TANIS

Indexed keywords

ARTICLE; CANCER STAGING; CHEEK; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; FEMALE; GINGIVA; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; OROPHARYNX; PALATE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TONGUE CANCER;

CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 80053001562     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21630     Document Type: Article

References (46)

1. Greene FL, Sobin LH,. The staging of cancer: a retrospective and prospective appraisal. CA Cancer J Clin 2008; 58: 180-190.
2. Woolgar JA, Hall GL,. Determinants of outcome following surgery for oral squamous cell carcinoma. Future Oncol 2009; 5: 51-61.
3. O'Sullivan B, Shah J,. New TNM staging criteria for head and neck tumors. Semin Surg Oncol 2003; 21: 30-42.
4. Hall SF, Groome PA, Irish J, O'Sullivan B,. TNM-based stage groupings in head and neck cancer: application in cancer of the hypopharynx. Head Neck 2009; 31: 1-8.
5. Hermanek P, Sobin LH, Fleming ID,. What do we need beyond TNM? Cancer 1996; 7: 815-817.
6. Groome PA, Schulze K, Boysen M, Hall SF, Mackillop WJ,. A comparison of published head and neck stage groupings in carcinomas of the oral cavity. Head Neck 2001; 23: 613-624.
7. Patel SG, Shah JP,. TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 2005; 55: 242-258; quiz 261-262, 264.
8. th Edition of the UICC's TNM Classification and Stage Grouping for Oral Cancer. J Surg Oncol [epub ahead of print.
9. Hart AA, Mak-Kregar S, Hilgers FJ, et al. The importance of correct stage grouping in oncology. Results of a nationwide study of oropharyngeal carcinoma in The Netherlands. Cancer 1995; 75: 2656-2662.
10. Jones GW, Browman G, Goodyear M, Marcellus D, Hodson DI,. Comparison of the addition of T and N integer scores with TNM stage groups in head and neck cancer. Head Neck 1993; 15: 497-503.
11. Snyderman CH, Wagner RL,. Superiority of the T and N integer score (TANIS) staging system for squamous cell carcinoma of the oral cavity. Otolaryngol Head Neck Surg 1995; 112: 691-694.
12. Carinci F, Farina A, Longhini L, Urso RG, Pelucchi S, Calearo C,. Is the new TNM (1997) the best system for predicting prognosis? Int J Oral Maxillofac Surg 1999; 28: 203-205.
13. Lydiatt WM, Shah JP, Hoffman HT,; Head and Neck Sites Task Force. American Committee on Cancer. AJCC stage groupings for head and neck cancer: should we look at alternatives? A report of the Head and Neck Sites Task Force. Head Neck 2001; 23: 607-612.
14. Berg H,. The prognostic relevance of the TNM Systems for oropharynx carcinomas. [Article in German Tumordiagn Ther 1992; 13: 171-177.
15. Carinci F, Pelucchi S, Farina A, Calearo C,. A comparison between TNM and TANIS stage grouping for predicting prognosis of oral and oropharyngeal cancer. J Oral Maxillofac Surg 1998; 56: 832-836; discussion 836-837.
16. Freier K, Engel M, Lindel K, et al. Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients. Oral Oncol 2008; 44: 116-123.
17. Kirita T, Ohgi K, Shimooka H, et al. Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results. Oral Oncol 1999; 35: 597-606.
18. Klug C, Wutzl A, Kermer C, et al. Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: outcome of 222 patients. Int J Oral Maxillofac Surg 2005; 34: 143-148.
19. Mohr C, Bohndorf W, Carstens J, et al. Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up). Int J Oral Maxillofac Surg 1994; 23: 140-148.
20. Slotman GJ, Doolittle CH, Glicksman AS,. Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival. Cancer 1992; 69: 2736-2743.
21. Fan KH, Lin CY, Kang CJ, et al. Combined-modality treatment for advanced oral tongue squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2007; 67: 453-461.
22. Soo KC, Tan EH, Wee J, et al. Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 2005; 93: 279-286.
23. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-1952.
24. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-1944.
25. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW,. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997; 38: 285-289.
26. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457-481.
27. Cox D,. Regression model and life-tables. J R Stat Soc 1972; 34: 187-220.
28. Groome PA, Schulze KM, Mackillop WJ, et al. A comparison of published head and neck stage groupings in carcinomas of the tonsillar region. Cancer 2001; 92: 1484-1894.
29. Groome PA, Schulze K, Boysen M, et al. A comparison of published head and neck stage groupings in laryngeal cancer using data from two countries. J Clin Epidemiol 2002; 55: 533-544.
30. Carinci F, Farina A, Pelucchi S, Brunelli G, Pastore A, Calearo C,. Stage grouping of oropharyngeal cancer: evaluation of three systems by means of survival analysis. J Craniofac Surg 1999; 10: 73-78.
31. Carinci F, Farina A, Pelucchi S, Calearo C, Pastore A,. Comparison between TANIS and UICC 1997 stage grouping in parotid gland carcinoma. J Craniofac Surg 2001; 12: 141-144.
32. Arduino PG, Carrozzo M, Chiecchio A, et al. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J Oral Maxillofac Surg 2008; 66: 1570-1579.
33. Lavaf A, Genden EM, Cesaretti JA, Packer S, Kao J,. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma. Cancer 2008; 112: 535-543.
34. Shaw RJ, Lowe D, Woolgar JA, et al. Extracapsular spread in oral squamous cell carcinoma. Head Neck 2010; 32: 714-722.
35. Kowalski LP, Bagietto R, Lara JR, Santos RL, Silva JF Jr, Magrin J,. Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck 2000; 22: 207-214.
36. Massano J, Regateiro FS, Januário G, Ferreira A,. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 67-76.
37. Burke HB,. Outcome prediction and the future of the TNM staging system. J Natl Cancer Inst 2004; 96: 1408-1409.
38. Driemel O, Ettl T, Kölbl O, et al. Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy. Strahlenther Onkol 2009; 185: 296-302.
39. Burke HB,. The power of prediction. Cancer 2008; 113: 890-892.
40. Gross ND, Patel SG, Carvalho AL, et al. Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma. Head Neck 2008; 30: 1352-1360.
41. Vora HH, Shah ND, Patel DD, Trivedi TI, Chikhlikar PR,. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. J Surg Oncol 2003; 82: 34-50.
42. Patel SG, Lydiatt WM,. Staging of head and neck cancers: is it time to change the balance between the ideal and the practical? J Surg Oncol 2008; 97: 653-657.
43. Thomson PJ, Goodson ML, Booth C, Cragg N, Hamadah O,. Cyclin A activity predicts clinical outcome in oral precancer and cancer. Int J Oral Maxillofac Surg 2006; 35: 1041-1046.
44. Shah NG, Trivedi TI, Tankshali RA, et al. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck 2009; 31: 1544-1556.
45. Yuan P, Temam S, El-Naggar A, et al. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 2006; 107: 563-569.
46. Kreppel M, Scheer M, Drebber U, Ritter L, Zöller JE,. Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations. Virchows Arch 2010; 456: 473-482.